Trials Sponsors Conditions Drugs Pricing

Conditions

Amyloid Neuropathy, Carpal Tunnel

Keywords

amyloidosis-carpal tunnel

Outcome Measures

Primary Outcomes (1)

presence of amyloid deposits
one month

Study Arms (1)

amyloid

unique cohort of Adult patients older than 21 years with carpal tunnel syndrome with surgical indication (moderate to severe symptoms that do not respond to conservative treatment physiotherapy, splinting, activity modification) for more than 6 months.

Eligibility Criteria

Age21 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Adult patients older than 21 years with carpal tunnel syndrome with surgical indication (moderate to severe symptoms that do not respond to conservative treatment physiotherapy, splinting, activity modification) for more than 6 months.

You may qualify if:

Adult patients older than 21 years with carpal tunnel syndrome with surgical indication (moderate to severe symptoms that do not respond to conservative treatment physiotherapy, splinting, activity modification) for more than 6 months.

Sponsors & Collaborators

Hospital Italiano de Buenos Aires
Otherlead

Study Sites (1)

HIBA

CABA, Buenos Aires, Argentina

MeSH Terms

Conditions

Amyloid NeuropathiesMedian Neuropathy

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesAmyloidosisProteostasis DeficienciesMetabolic DiseasesNutritional and Metabolic DiseasesMononeuropathies

Study Officials

Adela Aguirre, MD
Hospital Italiano de Buenos Aires
PRINCIPAL INVESTIGATOR
Lourdes Posadas-Martínez, MD
Hospital Italiano de Buenos Aires
PRINCIPAL INVESTIGATOR
Dorotea Fantl, MD
Hospital Italiano de Buenos Aires
PRINCIPAL INVESTIGATOR
María S. Saez, BCH
Hospital Italiano de Buenos Aires
PRINCIPAL INVESTIGATOR

Enrollment

0 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: CROSS SECTIONAL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: MD

Study Record Dates

First Submitted

April 1, 2014

First Posted

June 2, 2014

Study Start

June 1, 2017

Actual (reported)

Study Stopped

Prevalence of Amyloidosis and Carpal Tunnel

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

amyloid

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

amyloid

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations